Appears On
Episode Appearances
On The Pen GLP-1 News · May 5, 2026
He Took Retatrutide 40mg and Proved a Point
“Discussed development of Pivot app for GLP-1 journey tracking; explained patient feedback that drove app design”
Gray market GLP-1 access and safety risksRetatrutide dosing errors and adverse eventsFoundae (orfoglutide) liver safety signals
View Analysis